ArticleCardiovascular and interventional radiology2025
Genicular Artery Embolization using an Ethiodized Oil-based Emulsion in Fifty Knees: 12-Month Results.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Outcome and Safety of Genicular Artery Embolization for Knee Osteoarthritis: A Systematic Review and Meta-Analysis.Cardiovascular and interventional radiology · 2026Pooled it
- Genicular Artery Embolization for Chronic Knee Pain: Expert Consensus Recommendations on Indications, Technique and Clinical Care Using a Delphi Process.Cardiovascular and interventional radiology · 2026Article
- Genicular artery embolization as a minimally invasive treatment for knee osteoarthritis: systematic review and meta-analysis.Skeletal radiology · 2026Article
- Genicular Artery Embolization (GAE) for the Treatment of Advanced Knee Osteoarthritis in Selected Nonoperative Patients: A Pilot Study at 6 Months Follow-Up.Journal of clinical medicine · 2026Article
- Genicular Artery Embolization for Knee Osteoarthritis: Do Degradable Starch Microspheres Offer a New Therapeutic Option?Cardiovascular and interventional radiology · 2026Article
- Safety and Feasibility of Genicular Artery Embolization with Degradable Starch Microspheres for Knee Osteoarthritis: A One Year Experience and Preliminary Clinical Results.Cardiovascular and interventional radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeThe purpose of the study was to evaluate the mid-term efficacy of genicular artery embolization (GAE) using an ethiodized oil-based emulsion for the treatment of symptomatic knee osteoarthritis. MATERIALS AND
methodsThis was a single-arm, open-label, single-center, prospective cohort study. Inclusion criteria were GAE using an ethiodized oil-based emulsion for primary knee osteoarthritis. Exclusion criteria were absence of available follow-up longer than 3 months. Clinical efficacy was assessed using the Visual Analog Scale (VAS) pain score and the Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) scores.
resultsFifty consecutive GAEs in 46 patients (mean age, 67.4 years ± 9.8) with Kellgren-Lawrence grade from 2 to 4 knee osteoarthritis were included between March 2021 and November 2023. Technical success rate was 100%. No patient experienced complication in the target knee. Mean VAS pain score improved significantly from 71.8 mm ± 16.6 (Standard Deviation [SD]) at baseline to 36.8 mm ± 25.9 at 6 months (n = 41; p < 0.001) and to 37.8 mm ± 26.7 at 12 months (n = 37; p < 0.01). Mean WOMAC index score decreased significantly from 52.7 ± 17.6 at baseline to 30.9 ± 21.8 at 6 months (n = 37; p < 0.001) and to 29.0 ± 20.5 at 12 months (n = 33; p < 0.001). At 12 months, 45.9% (17/37) of the participants reached an acceptable symptom state defined by a VAS pain score < 32.3 mm.
conclusionGenicular artery embolization for symptomatic knee osteoarthritis using an ethiodized oil-based emulsion is safe and improves pain and function with a sustained efficacy at 12 months.
Indexed as
Identifiers
40770431What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.